Clean Energy Car Stocks Trading Alert; EVCARCO (OTCBB: EVCA) up 45% in Today's Trading

March 29, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com a leading global investor and industry portal covering the green and renewable energy sector reports on electric car stocks and battery stocks news and trading.
Oil is trading at $104.80 +0.82 +0.79%.
Electric car stock, EVCARCO (OTCBB: EVCA) (www.evcarco.com), is currently trading at $0.0270, up 0.0085 (45.95%).
Company Snapshot
EVCARCO (OTC.BB: EVCA) - Green, Electric Cars and Natural Gas Vehicles

EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles
Market Snapshot

• Dow 12,269.82 +71.94 +0.59%
• Nasdaq 2,749.63 +18.95 +0.69%
• S&P 500 1,316.63 +6.44 +0.49%
• 10 Yr Bond (%) 3.4950% +0.0470
• Oil 104.80 +0.82 +0.79%
• Gold 1,419.80 0.00 0.00%

Research electric car stocks and green auto stocks , lithium stocks - with the renewable energy stocks directory Research over 1300 green stocks - Investors also have the option to access the directory as part of the Investor Ideas Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
Investors - sign up for free stock alerts and investor news alerts
http://www.investorideas.com/Resources/Newsletter.asp
About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensated the site 500,000 144 shares in lieu of cash compensation.
To become a showcase company, contact us below.
For more information contact:
Email: dvanzant@investorideas.com or Cali at cvanzant@investorideas.com
Source: www.Investorideas.com

"Cleantech is getting more attention again from Wall Street and Independent Investors" - Josh Levine

New York, NY, Point Roberts WA, March 29, 2011 � Investorideas.com, a leader in cleantech investor research features a recent interview with Josh Levine of the MicroCap Investor newsletter, discussing cleantech investment strategies.

Rising oil prices and the recent nuclear disaster in Japan have created renewed interest in the cleantech sector that some analyst think is the real thing and here to stay .In an environment of rising oil prices, Levine sees major investment opportunities in Cleantech.
Josh discusses his recent addition to his portfolio and why and his overall strategy for finding cleantech plays in the microcap markets.
Investorideas.com Interview Excerpt:
Q: Investorideas.com
Josh, with oil prices surging above $100, cleantech is getting a lot more attention again from Wall Street and independent investors. I know you look at the long term investment picture, so what do you think is driving cleantech and what is your outlook for opportunities in this sector?
A: Josh Levine, MicroCap Investor
Let's first qualify what is meant by the term cleantech. Cleantech is often used interchangeably with green technologies and alternative energy, but it seems to be the one that's emerged to encompass all these things. Cleantech essentially covers technologies that are more energy-efficient than conventional technologies and offer more environmentally-friendly alternatives to fossil-fuel-driven energy applications.
Broadly speaking, the world is always moving towards more efficient use of resources. Year after year and decade after decade, we manage to get more out of a given amount of resources. The first industrial revolution was powered by coal and though it provided tremendous gains in production, the pollution negatively impacted the quality of life and health of millions of people.
Q: Investorideas.com
You recently just added a new cleantech stock to your portfolio. Can you give us some insight as to what qualified this particular stock based on your investing model?
A: Josh Levine, MicroCap Investor
My latest recommendation in unusual company which has developed and commercialized environmentally safe alternatives to plastics used for food containers, utensils, product wraps, as well as a wide range of parts in autos and many other things. Importantly, it meets all of my most important criteria for a great microcap investment.
As a cleantech play, this company's biodegradeable and completely safe products can replace petroleum-based polypropylene packaging. The result is less use of oil and a better outcome for the environment. It's a strong proposition.
It's a classic microcap story with all of the fundamentals in place for soaring growth -- a unique technology platform that's been validated by major customers worldwide, an experienced and proven management team, and powerful market drivers bolstered by increasing demand.
This company is addressing markets representing annual sales in the tens of billions of dollars, it has proven technology and products that are being rapidly adopted by large corporate customers, it has manufacturing capacity to scale several times current production, and its products are already on parity with polypropylene now that oil prices are north of $100.
In 2010, sales revenue for this company was $6.3 million, a 133% increase versus 2009, and projected revenue for the 2011 full year is between $24 million and $32 million -- a whopping 300% to 400% increase over 2010!
With all this going for it, this company is still valued well below $100 million. That's the kind of microcap opportunity I absolutely love!
Q: Investorideas.com
What percentage of your portfolio is in the cleantech space currently and are you looking to add more companies in the space over this year?
A: Josh Levine, MicroCap Investor
About one-third of the MicroCap Investor portfolio is devoted to cleantech companies, and I've got several top prospects in my sights. It's tough to predict, but I suspect I'll be adding at least a couple of more cleantech plays to our portfolio this year.
It's really a matter of quality, not quantity, and I am extremely bullish on the current group we have today. Still, cleantech is a ripe sector and it will yield tremendous opportunities year after year for a very long time. Every growth-oriented investor should make sure a healthy portion of his or her equities portfolio is allocated to cleantech.
Read the full Q&A Interview:
http://www.investorideas.com/news/2011/main/03031.asp
Josh Levine's MicroCap Investorhttp://www.levinesmicrocapinvestor.com
Levine's MicroCap Investor delves deep into the world of small stocks to identify big winners, targeting innovative companies on the path of the new and revolutionary.
The strategy for MicroCap Investor is simple: to focus on small, innovative companies representing the best pure plays in the fast-growing waves of change in biotechnology, cleantech, and emerging IT.
About Josh Levine
Levine has 25 years of senior-level experience in analyzing technology trends and investing in top-performing micro- and small-cap stocks. He excels at assessing management teams and evaluating new innovations and their impact on corporate valuations.
More on Levine's bio: http://www.levinesmicrocapinvestor.com/aboutus/
To learn more about the investment opportunities in the MicroCap Investor portfolio, and how to subscribe:
http://www.levinesmicrocapinvestor.com/subscriptions/order/
InvestorIdeas.com has partnered with Josh Levine and MicroCap Investor as part of its mission to provide investors with research tools to explore the world of small stocks. The InvestorIdeas.com team operates this web site and manages the administration and marketing for MicroCap Investor.
InvestorIdeas.com is a leading investment and industry research portal, with resources covering high-growth sectors including technology, biotech and cleantech.
Research cleantech stocks with the Investorideas.com renewable energy, water and environment stock directories. Learn more:
http://www.investorideas.com/membership/
Levine's Microcap Investor
Disclaimer:http://www.levinesmicrocapinvestor.com/disclosure/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising
Investorideas.com - a leader in cleantech investor research
Contact us
Dvanzant@investorideas.com
800 665 0411

Point Roberts, WA - March 29, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, reports on advances in Cancer Immunotherapy. Bristol-Myers Squibb Company (NYSE:BMY) announced Friday that the U.S. Food and Drug Administration (FDA) approved YERVOY� (ipilimumab) 3 mg/kg for the treatment of patients with unresectable (inoperable) or metastatic melanoma.

Bristol-Myers Squibb Company (NYSE:BMY) hit a 52 week high on Friday.
"The approval of YERVOY illustrates the power of harnessing the patient's own immune system to combat cancer," stated Jim Joyce, CEO of Aethlon Medical. "With the recent approval of PROVENGE from Dendreon, the cancer immunotherapy era seems to be well underway. In this regard, we believe that the elimination of particles released by cancers to suppress the immune response would further unlock the benefit of Yervoy, Provenge, and other immunotherapy candidates in the clinical pipeline."
Aethlon Medical (OTCBB: AEMD) recently discovered that it's Hemopurifier®, a dialysis-like device with broad-spectrum capabilities to capture infectious viral pathogens from circulation, also captures tumor-secreted exosomes that cause programmed cell death of the immune cells required to fight cancer.
Dendreon Corporation (NasdaqGS: DNDN ) was the first to receive FDA approval for its
PROVENGE® (sipuleucel-T) immune cell treatment of cancer. According to the company, it is the first autologous cellular immunotherapy AUTOLOGOUS CELLULAR IMMUNOTHERAPYPROVENGE is classified by the FDA as an autologous cellular immunotherapy. It is designed to be an active cellular immunotherapy. Closeto receive FDA approval for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. PROVENGE is designed to induce an immune response against prostate cancer.
RecentBristol-Myers Squibb Company (NYSE:BMY) News:
FDA Approves YERVOY™ (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer
First and Only Approved Therapy for Unresectable or Metastatic Melanoma to Demonstrate a Significant Improvement in Overall Survival
First FDA-Approved Therapy for Unresectable or Metastatic Melanoma in More than a Decade
First Approved Cancer Immunotherapy for Melanoma to Target CTLA-4 and First FDA-Approved Compound in the Company's Robust Immuno-Oncology Pipeline Risk Evaluation and Mitigation Strategy Developed with FDA to Support the Safe and Appropriate Use of YERVOY and Help Inform Patients and Providers About Important Safety Risks
PRINCETON, N.J. - (Investorideas.com Newswire) - Bristol-Myers Squibb Company (NYSE:BMY) announced that the U.S. Food and Drug Administration (FDA) approved YERVOY™ (ipilimumab) 3 mg/kg for the treatment of patients with unresectable (inoperable) or metastatic melanoma. YERVOY is the first and only therapy for unresectable or metastatic melanoma to demonstrate a significant improvement in overall survival based on results from a pivotal randomized, double-blind Phase 3 study. Median overall survival was 10 months (95% CI: 8.0-13.8) for YERVOY, 6 months (95% CI: 5.5-8.7) for gp100 and 10 months (95% CI: 8.5-11.5) for YERVOY + gp100, with p-values of 0.0026 (not adjusted for multiple comparisons) for YERVOY and 0.0004 for YERVOY + gp100 vs. gp100, respectively. As published in the New England Journal of Medicine, the Kaplan-Meier estimated survival rate at 1 year was 46% (95% CI: 37.0, 54.1) in the YERVOY arm vs. 25% (95% CI: 18.1, 32.9) in the gp100 arm. The estimated survival rate at 2 years was 24% (95% CI: 16.0, 31.5) in the YERVOY arm vs. 14%2 (95% CI: 8.0, 20.0) in the gp100 arm. YERVOY, which is a recombinant, human monoclonal antibody, is the first FDA-approved cancer immunotherapy that blocks the cytotoxic T- lymphocyte antigen-4 (CTLA-4).
Full News: http://www.investorideas.com/news/2011/main/03281.asp
Biotech/Pharma Sector Snapshot Trading March 28th
Aethlon Medical (OTCBB: AEMD) traded in a range: $0.13 - 0.1380
Bristol-Myers Squibb Company (NYSE: BMY ) Day's Range: $26.94 - $27.38 on over 18 Million shares
Dendreon Corporation (NasdaqGS: DNDN ) closed at $33.96, up $1.01 (3.07%) with further gains in after hours trading.
Company Snapshot
About Aethlon Medical (OTCBB: AEMD)
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
1.Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2.Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3.Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4.Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings .
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks with its portal BiotechIndustryStocks.com.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get added to the company's news alerts:
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech,  biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011      
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock)
Effective March 15, 2011

Oil and Gas Stocks News; American Petro-Hunter (OTCBB: AAPH) Announces NOS227 Well Completion Underway at North Oklahoma Project


SCOTTSDALE, AZ � March 29, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to announce that the NOS227 well completion is underway at the North Oklahoma Project. The work over rig has arrived on site and commenced activities in order to finish the well and put it into commercial production.

When completed, NOS227 will become the 3rd production well at the North Oklahoma Project in Payne County, Oklahoma. The well was drilled to 3,820 feet and the completion plan has begun to test and complete for immediate and future production of the three objective formations which include 85 feet in the Mississippi, 45 feet in the Woodford Shale, and 4 feet in the Simpson. It is anticipated that co-mingled Mississippi/Woodford production could result in 100 to 150 BPD potential.
Electronic log data of the oil bearing formations underlying NOS227 indicates that the lower Simpson formation provides oil shows offering excellent permeability and porosity and will be perforated and tested first. Following that, the Company plans to move up hole and acidize the Woodford which appears to have better porosity characteristics than what was encountered at the previously drilled No. 1 well where acidizing resulted in swab rates of 80 barrels per day. As part of the completion of this formation, a light fracture stimulation ("Frac") of the Woodford is anticipated. Lastly, the 85 foot thick Mississippi will be acidized and fracked.
All three zones contain oil shows having the requisite permeability and porosity to produce oil in commercial quantities and the well has been cased to depth. Based on an engineering analysis of the well and logs, the Company believes the possibility of a Mississippi-Woodford well with comingled production from both formations is estimated to have a 100-150 BPD potential. Additional production may occur from the Simpson however, as the zone is limited, it may prove prudent to hold the added resource behind pipe with the reserve categorized as Proved Undeveloped.
American Petro-Hunter has a 50% interest in the well. Production from NOS227 will be sold alongside output from the No. 1 and NOJ26 wells to Sunoco, the regional purchaser. West Texas Intermediate Crude today has recently been priced at $104 per barrel.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com

Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)

Clean Energy Stocks Alert; Clean Energy Fuels (Nasdaq:CLNE), (OTCBB:EVCA), (NasdaqGS:FSYS), (NasdaqGS:WPRT)

March 28, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com a leader in cleantech investor research, reports on recent clean energy vehicle news for investors following the sector. With the recent nuclear disaster in Japan, investors and industry are taking a more serious look at natural gas as a clean energy alternative. Stocks like Clean Energy Fuels Corp. (Nasdaq:CLNE) and Westport Innovations Inc (NasdaqGS: WPRT) have benefited from the renewed interest in clean energy fuel.

Oil is currently trading at $104.09 -1.31 -1.24%.
Alternative Energy Vehicle Sector Snapshot

• Clean Energy Fuels Corp. (Nasdaq:CLNE) $ 14.55, up 0.50 (3.56%) 2:17PM EDT
• EVCARCO (OTCBB: EVCA) trading a $0.018- 0.02, with a recent high of $0.10
• Fuel Systems Solutions, Inc. (NasdaqGS: FSYS ) trading at $25.63 0.38 (1.51%) 1:56PM EDT
• Westport Innovations Inc (NasdaqGS: WPRT ) (WPT.TO) trading at $19.08, up 0.36 (1.92%) 2:11PM EDT

Market Snapshot;

• Dow 12,239.58 +18.99 +0.16%
• Nasdaq 2,744.24 +1.18 +0.04%
• S&P 500 1,315.16 +1.36 +0.10%
• 10 Yr Bond (%) 3.4440% 0.0000
• Oil 104.09 -1.31 -1.24%

Company Snapshots
Clean Energy Fuels (Nasdaq:CLNE)
Clean Energy fuels more than 19,900 vehicles at 211 strategic locations across the United States and Canada with a broad customer base in the refuse, transit, trucking, shuttle, taxi, airport and municipal fleet markets. It owns (70%) and operates a landfill gas facility in Dallas that produces renewable methane gas, or biomethane, for delivery in the nation's gas pipeline network. It owns and operates LNG production plants in Willis, Texas and Boron, Calif. with combined capacity of 260,000 LNG gallons per day and that are designed to expand to 340,000 LNG gallons per day as demand increases. NorthStar, a wholly owned subsidiary, is the recognized leader in LNG/LCNG (liquefied to compressed natural gas) fueling system technologies and station construction and operations. BAF Technologies, Inc., a wholly owned subsidiary, is a leading provider of natural gas vehicle systems and conversions for taxis, vans, pick-up trucks and shuttle buses. IMW Industries, Ltd., a wholly owned subsidiary based in Canada, is a leading supplier of compressed natural gas equipment for vehicle fueling and industrial applications with more than 1,000 installations in 24 countries.
EVCARCO (OTC.BB: EVCA) - Green, Electric Cars and Natural Gas Vehicles
EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles
Recent News
Natural Gas News; EVCARCO (OTCBB: EVCA) to Sell Class 3-5 Commercial Compressed Natural Gas Powered Trucks at Its Green Auto Dealerships
Full news: http://www.investorideas.com/news/2011/energy/02151.asp
Westport Innovations Inc (NasdaqGS: WPRT ) is a global leader in alternative fuel, low-emissions technologies that allow engines to operate on clean-burning fuels such as compressed natural gas (CNG), liquefied natural gas (LNG), hydrogen, and biofuels such as landfill gas. Our unique technologies reduce nitrogen oxides (NOx), particulate matter (PM), and greenhouse gas emissions (GHG) while preserving the power, torque, and fuel efficiency of diesel engines. The Company focuses on three distinct categories or target markets - light-, medium-, and heavy-duty - through Westport business units or joint ventures. Juniper Engines is focused on 2.4L engines for industrial applications such as forklifts, oilfield service engines and light-duty automotive. Cummins Westport (CWI), a joint venture with Cummins, sells the world's broadest range of low-emissions alternative fuel engines for commercial urban fleets such as buses, refuse trucks and vocational vehicles ranging from 5.9L to 8.9L. Westport Heavy Duty (Westport HD), our proprietary development platform, is engaged in the engineering, design and marketing of natural gas-enabling technology for the heavy-duty diesel engine and truck market
Research green car stocks, lithium stocks - with the renewable energy stocks directory Research over 1300 green stocks - Investors also have the option to access the directory as part of the Investor Ideas Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
Investors - sign up for free stock alerts and investor news alerts
http://www.investorideas.com/Resources/Newsletter.asp
About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensated the site 500,000 144 shares in lieu of cash compensation.

Wind Stocks Trading Alert; Clean Wind Energy Tower, Inc. (OTCBB: CWET), PowerShares Global Wind Energy (NasdaqGM: PWND), China Ming Yang Wind (NYSE: MY)

Point Roberts, WA - March 28, 2011 - Investorideas.com, a leader in cleantech stock research, reports on recent wind stocks news and developments for wind stocks. New wind stocks were recently added to the NASDAQ OMX Clean Edge Global Wind Energy Index. Wind stocks and solar stocks continue to be in the spotlight with investors looking for alternatives to nuclear power and oil.

Oil is trading at $104.43 -0.97 -0.92%.
Wind Stocks Snapshot; Morning Trading
Wind ETF's

• First Trust ISE Global Wind Energy (NYSEArca: FAN ) trading at 11.80, up 0.28 (2.43%) 1:11PM EDT
• PowerShares Global Wind Energy (NasdaqGM: PWND ) trading up at 11.41, up 0.25 (2.24%)
• Wind Stocks
• Broadwind Energy, Inc. (NasdaqGS: BWEN ) trading at $ 1.36, down 0.01 (0.73%)
• China Ming Yang Wind Power Group (NYSE: MY ) trading at $10.27, up 0.17 (1.68%) 12:53PM EDT
• Clean Wind Energy Tower, Inc. (OTCBB: CWET) trading at $0.24
• Juhl Wind Inc. (OTCBB: JUHL) trading at $ 1.10. down 0.05 (4.35%)
• Plutonic Power Corporation (PCC.TO) trading at $ 2.73, down 0.01 (0.36%)

Market Snapshot

• Dow 12,250.75 +30.16 +0.25%
• Nasdaq 2,746.94 +3.88 +0.14%
• S&P 500 1,316.85 +3.05 +0.23%
• 10 Yr Bond (%) 3.4500% +0.0060
• Oil 104.43 -0.97 -0.92%
• Gold 1,426.10 0.00 0.00%

Recent Wind News:
Clean Wind Energy Tower, Inc. (OTCBB: CWET) Files Unique Hydraulic System Patent
Maximizing the Capture and Use of Available Wind Tunnel Energy
ANNAPOLIS, MD - March 7, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
Full news: http://www.investorideas.com/CO/CWE/news/2011/03071.asp
Semi-Annual Changes to the NASDAQ OMX Clean Edge Global Wind Energy Index
NEW YORK , March 21, 2011 -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) and Clean Edge, Inc. announced today the results of the semi-annual evaluation of the NASDAQ OMX(R) Clean Edge(R)
Global Wind Energy Index (Nasdaq:QWND), which will become effective with the market open today.
The following four securities will be added to the Index: ABB Ltd (ABBN VX), Broadwind Energy, Inc. (BWEN UQ), Enel Green Power S.p.A. (EGPW EB), and China Ming Yang Wind Power Group Limited (MY UN).
The Index is designed to act as a transparent and liquid benchmark for the global wind energy sector. The Index includes companies that are primarily manufacturers, developers, distributors, installers, and users of energy derived from wind sources. The securities must also meet other eligibility criteria which include minimum requirements for market capitalization and average daily dollar trading volume. The NASDAQ OMX(R) Clean Edge(R) Global Wind Energy Index is evaluated semi-annually in March and September. For more information about the NASDAQ OMX(R) Clean Edge(R) Global Wind Energy Index, including detailed eligibility criteria, visit https://indexes.nasdaqomx.com/.
The NASDAQ OMX Clean Edge Global Wind Energy Index is the basis for the PowerShares Global Wind Energy Portfolio (Nasdaq:PWND - News), which seeks investment results that correspond generally to the price and yield of the NASDAQ OMX Clean Edge Global Wind Energy Index before fees and expenses.
As a result of the evaluation, the following four securities will be removed from the Index: Japan Wind Development Co., Ltd. (2766 JT), ABB Ltd -- ADR (ABB UN), Endesa SA (ELE SM), and Enel SpA (ENEL IM).
About NASDAQ OMX Global Index Group
NASDAQ OMX Global Index Group is engaged in the design, development, calculation, licensing, and marketing of NASDAQ OMX Indexes. NASDAQ OMX Global Index Group specializes in the development of indexes focusing on NASDAQ OMX's brand themes of innovation, technology, growth, and globalization. NASDAQ OMX Global Index Group also provides custom index services and design solutions as a third-party provider to selected financial organizations. For more information about NASDAQ OMX indexes, visit www.nasdaq.com/indexes.
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Wind Company Snapshot
Clean Wind Energy Tower, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc., was established to commercialize a number of proven and validated technologies and construction systems into a single large downdraft tower structure that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, Clean Wind Energy, Inc. has assembled a world class team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market.
Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology. The Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity .
www.cleanwindenergytower.com
Visit the showcase page at Investorideas.com : http://www.investorideas.com/CO/CWE/
Broadwind Energy (NASDAQ:BWEN ) applies decades of deep industrial expertise to innovate integrated solutions for customers in the energy and infrastructure markets. From gears to wind towers, to comprehensive remanufacturing of gearboxes and blades, to operations and maintenance services, and heavy industries, we have solutions for the energy needs of the future. With facilities throughout the U.S., Broadwind Energy's talented team of more than 800 employees is committed to helping customers maximize performance of their investments—quicker, easier and smarter. Find out more at www.bwen.com.
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on (OTCBB: CWET)
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares ) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com

How a Specialty Pharmaceutical Company Leads the Way; Phase III Clinicals for the Only
Product Currently Addressing Female Sexual Dysfunction

March 28 , 2011 - (Investorideas.com newswire.com) Investorideas.com, an investor research
portal covering leading sectors including biotech stocks and pharma stocks, features an exclusive
Q&A interview and update with Mr. Stephen M. Simes, President and Chief Executive Officer of
BioSante Pharmaceuticals.

Stephen M. Simes, discusses how specializing in a product for female sexual dysfunction and
leading in development with LibiGel® in Phase III clinicals, makes BioSante Pharmaceuticals
(NASDAQ: BPAX) a company to watch.

JMP Securities released a report this month with a price target of $5.00. Mr. Simes gives his
insight as the company’s leader as to why the future looks so bright.

BioSante Pharmaceuticals Interview

Q: Investorideas.com
As you move forward with development of LibiGel® and other products in the pipeline, is your
company able to execute in terms of funding and cash available ? – and up to what time period?

A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
It is quite interesting that a full 13 years after Viagra was approved for treating men’s
sexual issues, women still do not have an approved product to treat their sexual health.
Today, BioSante is the only company in the world in Phase III clinical development for the
treatment of women’s sexual dysfunction, specifically hypoactive sexual desire disorder.
This represents a major opportunity for BioSante and women since we expect to be first to
market with our LibiGel which is in several Phase III studies.

Q: Investorideas.com
JMP Securities recently released research on your company as an “underfollowed and
undervalued microcap company” and has placed a $5.00 target price. They note “Our $5
price target is derived by applying a 5x multiple to our base case projection for LibiGel sales
of $422MM in 2016, discounted by 30% per year. “ Can you comment on their revenue
projections ?

A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
We believe the market potential for products like LibiGel is over $1 billion. This is derived
from many factors including the fact that the erectile dysfunction market in the U.S. alone
is over $2 billion and the market for male testosterone products is over $1 billion.

Q: Investorideas.com
The Company recently reported financial results and a pipeline update . Can you give us a

summary of what the pipeline looks like outside of LibiGel® ?

A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
Yes, we have a full pipeline of products. Elestrin is our already approved estrogen product for the
treatment of hot flashes in menopausal women and Bio-T-Gel is our male testosterone product.
We hope to announce an FDA submission of Bio-T-Gel in the near future. In addition, we have a
full portfolio of cancer vaccines in clinical trials.

About LibiGel® LibiGel® is a gel formulation of testosterone in development that is quickly
absorbed through the skin after a once-daily application of a pea-sized dose of gel on the upper
arm, delivering testosterone to the bloodstream evenly over time and in a non-invasive and
painless manner. Though generally characterized as a male hormone, testosterone also is
present in women and its deficiency has been found to decrease libido or sex drive. In addition,
studies have shown that testosterone therapy can increase bone density, raise energy levels and
improve mood, in addition to boosting sexual desire and activity.

Currently, BioSante is conducting three Phase III clinical studies to demonstrate the safety
and efficacy of LibiGel to increase sexual desire and satisfying sexual events and to decrease
distress associated with the decreased desire. Two Phase III safety and efficacy trials that are
underway are randomized, double-blind, placebo-controlled trials which will enroll approximately
500 surgically menopausal women each for six-months of treatment. BioSante is conducting
these trials under an FDA agreed special protocol assessment (SPA). In addition, BioSante has
another SPA agreement with the FDA related to treatment of naturally menopausal women.
The SPA process and agreement confirms the FDA’s position that FSD and HSDD are true
conditions that women experience, with measurable endpoints, that can be evaluated and which
deserve therapeutic options. It also affirms that the FDA agrees that the LibiGel Phase III safety
and efficacy clinical trial design, clinical endpoints, sample size, planned conduct and statistical
analyses are acceptable to support regulatory approval. Further, it provides assurance that these
agreed measures will serve as the basis for regulatory review and the decision by the FDA to
approve an NDA for LibiGel.

About BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)
BioSante (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing
products for female sexual health and oncology. BioSante’s lead products include LibiGel®
(transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is
in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special
Protocol Assessment. BioSante’s first FDA-approved product is Elestrin™ (estradiol gel)
indicated for the treatment of hot flashes associated with menopause, marketed in the U.S.
by Azur Pharma, BioSante’s licensee. BioSante also is developing a portfolio of cancer
vaccines, four of which have been granted Orphan Drug designation, and are currently in
several Phase II clinical trials. Other products are Bio-T-Gel™, a testosterone gel for male
hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical
development using BioSante patented technology. Additional information is available online at:
www.biosantepharma.com.

Visit the company profile on Investorideas.com: http://www.investorideas.com/CO/BPAX/
Or the company website www.biosantepharma.com to learn more about BioSante.

Request News & Updates from BioSante (NASDAQ: BPAX) on the Investorideas.com sign up
page: http://www.investorideas.com/Resources/Newsletter.asp

Recent Research

JMP Securities

We are initiating coverage on BioSante Pharmaceuticals with a Market Outperform rating
and price target of $5. We view BioSante as an underfollowed and undervalued microcap
company with a late-stage development asset that has better than average clinical risk.
BioSante's lead product candidate is LibiGel, a proprietary formulation of testosterone delivered
through the skin being developed for the treatment of female sexual dysfunction, for which there
is currently no approved therapy. We believe that with clarity emerging on timelines for key value-
driving LibiGel catalysts, institutional interest will increase and the market inefficiency in the
current valuation can begin to resolve. Our $5 price target is derived by applying a 5x multiple to
our base case projection for LibiGel sales of $422MM in 2016, discounted by 30% per year.
Full report :
http://www.investorideas.com/CO/BPAX/news/Initiating-Coverage-031611.pdf

About InvestorIdeas.com:

InvestorIdeas.com is a leading global investor and industry research resource portal specialized
in sector investing covering over thirty industry sectors and global markets including China,
India, the Middle East and Australia. Our leading biotech portal within our content umbrella,
www.BiotechIndustryStocks.com, covers the biotech/pharma sector for independent investors
with company profiles, news and stock directories.

Disclaimer: The following BioSante Pharmaceuticals, Inc company profile is a paid for submission (one thousand per
month) Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy
of information presented. All Information relating to featured companies is sourced from public documents and/ or the
company and is not the opinion of our web sites. This site is currently compensated by featured companies, news
submissions, company profile submissions and online advertising. http://www.investorideas.com/About/Disclaimer.asp
Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

Forward-Looking Statements

To the extent any statements made in this news release deal with information that is not historical, these are forward-
looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are
not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future
operations and products, the timing of anticipated regulatory submissions and other statements identified by words such
as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may,"
other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that
are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different
than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties
and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other
approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success
of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these
and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities
and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on
Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante
undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future
events or otherwise.

For info about BioSante Pharmaceuticals, Inc

Contact:
For Investors:

The Trout Group LLC
Tricia Swanson
(646) 378-2953; tswanson@troutgroup.com

For Additional Information about Investorideas.com:

C Van Zant: 800-665-0411 – cvanzant@investorideas.com

Source – Investorideas.com

Energy Stocks to Watch for March 28th; (OTCBB: AAPH), (NASDAQ:TNGS), (NASDAQ:IVAN), (OTCBB: UTOG)


Point Roberts, WA - March 28, 2011 (Investorideas.com Energy Newswire) - InvestorIdeas.com, a leader in sector research for investors including energy stocks, reports on oil and gas stocks to watch March 28th.

Oil closed at $105.05 -0.35 -0.33%. Spreading unrest across the Middle East keeps oil above US$100. US stocks showed gains on Friday due to corporate earnings and improved economic data. Oil prices are a wild card in terms of how high it will go and at what point it starts to hurt the economic growth.
One way for investors to play the rising oil prices is to trade stocks within the sector.
Energy stocks to watch include American Petro-hunter Inc (OTCBB: AAPH), Halliburton Company (NYSE: HAL), ATP Oil & Gas Corp. (NASDAQ: ATPG), and Ivanhoe Energy Inc. (NASDAQ: IVAN).
Sector Snapshot: (Trading at close March 25)

• American Petro-hunter Inc (OTCBB: AAPH) trading at $0.35, up 0.02 (6.06%)
• Titan Oil & Gas, Inc. (OTCBB: TNGS) trading at $1.30, up 0.02 (1.56%)
• Ivanhoe Energy Inc. (NASDAQ: IVAN) trading at $2.97, up 0.02 (0.68%)
• UNIONTOWN ENERGY INC, (OTCBB: UTOG) tradingat $1.71 on over 5 Million shares in volume

Oil and Gas Stocks News
American Petro-hunter Inc (OTCBB: AAPH) Recent Press
Latest News:
Oil Stocks News Alert; American Petro-Hunter (OTCBB: AAPH) Adds 2,000 Acres of Prime Horizontal Well Opportunities at North Oklahoma Project
"SCOTTSDALE, AZ - March 25, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") today is pleased to announce that the Company has acquired a majority working interest in an additional 2,000 acres of lands located in Payne County, Oklahoma. The acreage augments the Company's holdings at the North Oklahoma Project to 3,400 total gross acres.
With this recent acquisition, the Company has designated the new lands as the "Ripley Prospect" and the original lands as the "Yale Prospect," with both areas held as regional components of the North Oklahoma Project. The newly acquired Ripley acreage is located in a key area of an emerging horizontal drilling play where over 100 foot thick sections of Mississippi Formation are currently being aggressively exploited by regional players deploying laterally drilled, horizontal wells.”
Full News at¨http://www.investorideas.com/CO/AAPH/news/2011/03251.asp
About American Petro-Hunter, Inc. (OTC.BB:AAPH )
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas and the North Oklahoma Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Visit the AAPH showcase profile on Investorideas.com:
http://www.investorideas.com/CO/AAPH/
UNIONTOWN ENERGY INC, (OTCBB: UTOG) Recent Press
Latest News:
UnionTown Energy Inc. Announces Major Authorized Stock Reduction " BILLINGS, MT-- - 03/25/11 - UnionTown Energy Inc. (OTC.BB: UTOG) today reported the initiation of a reduction in authorized capital to 300 million common shares to provide strong shareholder protection and exceptional corporate growth. The Company is focused on shareholder value and views this corporate action as a major step in propelling Uniontown Energy towards its goal of becoming a successful major oil and gas entity.
The Company is discussing agreements with counsel for the immediate CUSIP and a name change to accommodate the aggressive corporate moves to acquisition and production. This may result in delivery of all Union Energy Inc. stock to the Company's current transfer agent on an immediate delivery protocol.”
Full News at: http://finance.yahoo.com/news/UnionTown-Energy-Inc-iw-1382215689.html?x=0&.v=1
Ivanhoe Energy Inc. ( NASDAQ: IVAN) Recent Press
Latest News:
Ivanhoe Energy reports 2010 financial results and operational highlights
" CALGARY, March 17 Ivanhoe Energy Inc. (NASDAQ:IVAN) today announced summary financial results and operating highlights for the year ended December 31, 2010. All figures reported are in US dollars unless otherwise noted. Ivanhoe Energy has filed its annual report on Form 10-K for the year ended December 31, 2010.
Highlights
Ivanhoe Energy marked a major advance towards commercial production at its Tamarack Project with the submission of its regulatory application to the Government of Alberta in November 2010.
Subsequent to year end, Ivanhoe Energy announced that probable plus possible reserves were recognized for the Tamarack Project. GLJ Petroleum Consultants of Calgary assigned estimated (2P) bitumen reserves of 176 million barrels and probable plus possible (3P) bitumen reserves of 220 million barrels and probable to Tamarack. Along with the reserves additions, the independent 2010 evaluation recognized 345 million barrels of best estimate contingent resource.”
Full News at: http://finance.yahoo.com/news/Ivanhoe-Energy-reports-2010-prnews-2576133429.html?x=0&.v=28
Titan Oil & Gas, Inc. ( OTCBB: TNGS) Recent Press
Latest News:
Titan Oil & Gas Provides Update on Production Opportunities
"Press Release Source: Titan Oil & Gas Inc. On Tuesday March 22, 2011
LAS VEGAS , NV-- - Titan Oil & Gas, Inc. (OTC.BB: TNGS) ("Titan" or "the Company") is pleased to provide an update on recent corporate developments.
In the past thirty days, several groups have approached Titan with a large number of partnership, acquisition, and joint venture opportunities.
Titan has completed its initial review of approximately twenty properties and as a result of its due diligence process, has identified three high-priority targets. Each target has the potential for immediate production and would provide the company with near-term cash-flow.”
Full News at: http://finance.yahoo.com/news/Titan-Oil-Gas-Provides-Update-iw-481847867.html?x=0
About InvestorIdeas.com:
Sign up for free investor stock alerts :
http://www.investorideas.com/Resources/Newsletter.asp
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Oil and Gas portal:
Research more energy stocks:
Visit the oil and gas stocks directory listing publicly traded stocks from multiple global stock exchanges including TSX, ASX, OTC, NASDAQ and NYSE.
http://www.investorideas.com/OGSN/Stock_List.asp
www.OilandGasStocksNews.com is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories. Investors can also follow energy commentary from energy expert Karl Miller.
Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH ( averaging two thousand per month). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer:http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on American Petro-hunter Inc ( OTCBB: AAPH) contact the company IR directly.
For info on Investorideas.com
Contact:
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)

Energy Stocks News; American Petro-Hunter (OTCBB: AAPH) Adds 2,000 Acres of Prime Horizontal Well Opportunities at North Oklahoma Project

SCOTTSDALE, AZ � March 25, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") today is pleased to announce that the Company has acquired a majority working interest in an additional 2,000 acres of lands located in Payne County, Oklahoma. The acreage augments the Company's holdings at the North Oklahoma Project to 3,400 total gross acres.

With this recent acquisition, the Company has designated the new lands as the "Ripley Prospect" and the original lands as the "Yale Prospect," with both areas held as regional components of the North Oklahoma Project. The newly acquired Ripley acreage is located in a key area of an emerging horizontal drilling play where over 100 foot thick sections of Mississippi Formation are currently being aggressively exploited by regional players deploying laterally drilled, horizontal wells.
Surrounding the Ripley Prospect, numerous lease holdings are under development by Tulsa-based Calyx Energy, a private company. To date, Calyx has drilled 3 horizontal wells on leases within a mile and a quarter (1� mile) south of the Ripley block and, of major significance to the Company, the nearby C&N 25-1H well has been speculated to have had initial production rates (I.P.) of 1,000 barrels per day (BPD). Calyx also has plans for further wells immediately north of our Ripley Prospect holdings and is currently exploiting prospects on over 40,000 acres in central and eastern Oklahoma.
The 2,000 acre Ripley Prospect block is now part of the central focus of the Company's 2011 development plan. A location for our first Mississippi horizontal has been engineered and proposed. The 1,500 to 4,000 foot lateral will drill down and along the Mississippi which sits directly over the Woodford Shale. The lease block would allow, if successful, for the drilling of 5 horizontals on 320 acre parcels. Further information will be released regarding potential spud dates and particulars on the play.
Company President Robert McIntosh states, "We are very pleased to have added this encouraging and very interesting horizontal Mississippi play to the North Oklahoma Project. With the new drilling combined with our existing lands encompassing both Woodford and Mississippi prospects, we have secured sufficient acreage to drill many horizontal and vertical wells in 2011. If we are successful, we will rapidly move the Company forward to our stated production goals and targets."
Given the added expense of horizontal drilling, American Petro-Hunter has developed a prudent "watch & learn" approach based on the experiences of the well-funded major operators at the Yale Prospect area. As the drill programs currently under development by the major players adjacent to our Yale Prospect are not yet underway, the opportunity to quickly move into a proven and highly productive area less than 10 miles away at Ripley presented itself as a desirable near term opportunity. The Company will continue to explore and develop vertical wells in the Yale area and plans to immediately follow up the NOS227 well dependent on completion results.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com

Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)

Electric Car Stocks Trading Alert; (OTCBB: EVCA), (NASDAQ: TSLA, (NASDAQ:AONE),
(Nasdaq:MXWL)

Maxwell Technologies, Inc. (Nasdaq:MXWL) trading up at $17.04, up 0.52 (3.15%)

March 25, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com a
leader in cleantech investor research, reports on electric car stocks and battery stocks trading for
March 25th. As markets give investors another positive trading day, the sector shows strength.
Oil is trading at $104.91 -0.69 -0.65 %, off for the day, but high enough to be a driving factor for
the alternative energy sector.

Electric Car Sector Snapshot
A123 Systems, Inc. (NasdaqGM: AONE) trading at $ 7.86, up 0.03 (0.38%) 12:55PM EDT
ENER1, Inc. (NASDAQ: HEV) trading at $ 2.96, up 0.05 (1.72%)
Ecotality, Inc. (NasdaqCM: ECTY) trading at $2.84, down 0.05 (1.73%) 11:45AM EDT
EVCARCO (OTCBB: EVCA)) trading at $ 0.0215
Maxwell Technologies, Inc. (Nasdaq:MXWL) trading up at $17.04, up 0.52 (3.15%) 12:59PM EDT
NRG Energy, Inc.(NYSE: NRG ) trading at $21.39, up 0.25 (1.18%) 1:03PM EDT
Tesla Motors, Inc. (NASDAQ: TSLA) trading at $ 22.85, up 0.52 (2.33%) 12:44PM EDT
UQM Technologies, Inc. (NYSE Amex: UQM) trading at $3.08, down 0.06 (1.91%) 1:04PM EDT

Market Snapshot
Dow 12,236.25 +65.69 +0.54%
Nasdaq 2,756.86 +20.44 +0.75%
S&P 500 1,317.14 +7.48 +0.57%
10 Yr Bond(%) 3.4240% +0.02
Oil 104.91 -0.69 -0.65%
Gold 1,434.80 0.00 0.00%

Company Snapshot

EVCARCO (OTC.BB:EVCA)- Green , Electric Cars and Natural Gas Vehicles
EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated
to deploying a coast-to-coast network of environmentally friendly franchised dealerships and
vehicles. EVCARCO is bringing to market the most advanced clean technologies available in
plug-in electric, alternative fuel, and pre-owned hybrid vehicles.

Recent Industry News :
Environment Agency goes pure electric with Mitsubishi i-MiEV
25th March 2011 Print Email Share

After decades of experimentation, innovation and trials, the future of motoring is
here and today sees the Environment Agency take delivery of its first pure-electric
vehicle (EV) in a bid to reduce the organisation’s carbon footprint. The event coincides
with Climate Change Week which is aimed at demonstrating what can be done by
businesses and individuals to reduce CO2 and to encourage more people to act on
climate change.
Full news: http://www.easier.com/86402-environment-agency-mitsubishi-i-miev.html

Research electric car stocks and green auto stocks, lithium stocks - with the renewable

energy stocks directory Research over 1300 green stocks - Investors also have the option to
access the directory as part of the Investor Ideas Investors also have the option to access the
directory as part of the Investor Ideas Membership premium content that currently features
an additional 10 stock directories, including the water stocks directory and all cleantech stock

directories. http://www.investorideas.com/membership/

Investors - sign up for free stock alerts and investor news alerts
http://www.investorideas.com/Resources/Newsletter.asp

About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable
energy stocks and has become a global go-to destination for investors researching the cleantech
sector, with stock directories, company news, commentary from experts, research reports and
industry resources and links. Investors can follow solar stocks commentary on our site with solar
expert, J. Peter Lynch.

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly,
but we offer no guarantees as to the accuracy of information presented. All Information relating
to featured companies is sourced from public documents and/ or the company and is not the
opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies
EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensated the site
500,000 144 shares in lieu of cash compensation.

To become a showcase company, contact us below.
For more information contact:
Email: dvanzant@investorideas.com or Cali at cvanzant@investorideas.com
Source: www.Investorideas.com

Gold Stocks; Gold Bullion (TSX-V: GBB) Appoints Ronald Goguen Sr. to The Board Of Directors

Vancouver, British Columbia - March 24, 2011 (Investorideas.com Mining stocks Newswire) - Mr. Frank J. Basa reports: Gold Bullion Development Corp. (CDNX:GBB.V) (Other OTC:GBBFF.PK) (the "Company" or "Gold Bullion") is pleased to announce the appointment of Ronald Goguen, Sr. to the Company�s Board of Directors.

Mr. Goguen is the founding shareholder of Landdrill International Inc.'s predecessor company, and has been President and Chief Executive Officer of Landdrill since taking it public in March 2006. Mr. Goguen purchased his first exploration drilling company, Ideal Drilling, in 1980. In 1981, he added a second exploration drilling company and increased sales and net income significantly. Those companies were combined to become Major Drilling Group International Inc., a publicly traded company that has traded on the Toronto Stock Exchange since March 1995. Mr. Goguen served as President and Chief Executive Officer until 2000, and during this time was a key driving force in building Major Drilling into one of the largest mineral drilling service companies in the world (33 operations in 15 countries).
Since leaving Major Drilling in 2000, Mr. Goguen has served as the President of Royal Oaks Real Estates Inc. and Royal Oaks Golf & Country Club. During 2006 Mr. Goguen was appointed Chairman of the Board of Directors for Beaver Brook Antimony Mine Inc., and he remained so until bringing its operation into production during early 2008. Beaver Brook is the largest antimony mine outside of China. Now that this company is operating, management has been put in place to carry on its operation and Mr. Goguen remains one of its directors. Mr. Goguen is currently a member of the board of directors of Northeast Bancorp, Saratoga Capital Management and Colibri Resource Corporation. During 1995 Mr. Goguen was named Atlantic Canada's entrepreneur of the year as presented by the Governor General of Canada.
About Gold Bullion Development Corp.
Gold Bullion Development Corp. is a TSX Venture listed junior natural resource company focusing on the exploration and development of its Granada Gold Property near Rouyn-Noranda, Quebec, and its high grade Castle Silver Mine in Gowganda, Ontario.
For more information on Gold Bullion Development Corp. (TSX-V: GBB, OTC PK: GBBFF), visit our web site: http://www.GoldBullionDevelopmentCorp.com
Frank J. Basa, P.Eng.
President and Chief Executive Officer
For further information contact:
Frank J. Basa, P.Eng., President and CEO: 1-416-625-2342
Roger Thomas, Director: 1-613-292-2438
Progressive Investor Relations (Canada) Tel (604) 689-2881 or email info@progressive-ir.com
Torrey Hills Capital (United States) Tel (858) 456-7300
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.

Visit the GBB showcase profile at Investorideas.com
Request News and Info on GBB
Disclosure, Disclaimer/ GBB is a paid advertising client on Investorideas.com and our mining portals.